Note: Ariad Pharmaceuticals's revenues are gauged from an analysis of company filings.
Trademark applications show the products and services that Ariad Pharmaceuticals is developing and marketing.
Ariad Pharmaceuticals doesn't have any recent trademark applications, indicating Ariad Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
LIVINGWITHALK Providing health information, in the field of anaplastic lymphoma kinase positive cancer
EVOBRIG Pharmaceutical preparations for use in oncology
ALKCONNECT Maintaining a registry of patient data and medical information, in the field of anaplastic lymphoma kinase positive cancer
Determine whether Ariad Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Ariad Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Ariad Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Ariad Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Ariad Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Ariad Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.